The Pancreatic Cancer Detection Consortium (PCDC) is a major program of the National Cancer Institute (NCI). The objective of the PCDC is to bring together investigators funded through NCI-supported programs on pancreatic cancer detection and stakeholders that are supporting biomarker research. These individuals meet to discuss and debate existing or newly developed biomarkers that are likely to improve the detection of pancreatic cancer.

The Kenner Family Research Fund has been a member of the steering committee since 2016, and along with Pancreatic Cancer Action Network, is one of only two foundations in the Consortium.